
Vivos Therapeutics, Inc. (NASDAQ: VVOS) is an innovative medical technology company focused on the development and commercialization of screening and treatment for obstructive sleep apnea (OSA). Vivos offers a multidisciplinary treatment protocol that uses nonsurgical, noninvasive, and cost-effective oral appliance technology prescribed by trained dentists and medical professionals to treat dentofacial anomalies and/or mild to moderate OSA. This revolutionary treatment is called the Vivos Method. Combining technologies and protocols that alter the size, shape, and position of the tissues of the upper airway, the Vivos Method opens airway space and can significantly reduce or even eliminate the symptoms and conditions associated with mild to moderate OSA. Read More